Skip to content

A study to evaluate the effect of nasal administration of Brihat Shatavari Ghrita in the management of Premenstrual syndrome

A controlled clinical study to evaluate the add on effect of Brihat Shatavari Ghrita as Prathimarsha nasya in the management of Premenstrual syndrome vis-a-vis Pittavruta vyana vata - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070654
Enrollment
50
Registered
2024-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E319- Polyglandular dysfunction, unspecified

Interventions

None listed

Sponsors

Dr Hitha M K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects diagnosed based on diagnostic criteria (Premenstrual Syndrome Scale) Subjects having regular menstrual cycle (21-35 days)

Exclusion criteria

Exclusion criteria: Any diagnosed clinical condition that interferes with the clinical trial Subjects under hormonal treatment

Design outcomes

Primary

MeasureTime frame
To evaluate the add on effect of Brihat Shatavari Ghrita as Prathimarsha Nasya over Punarnavadi Kashaya and Ashwagandha Churna in Premenstrual SyndromeTimepoint: 21-35 days (after 1st menstrual cycle)

Secondary

MeasureTime frame
To evaluate the combined effect of Brihat Shatavari Ghrita as Prathimarsha Nasya over Punarnavadi Kashaya and Ashwagandha Churna in Premenstrual SyndromeTimepoint: 21-35 days (after 1st menstrual cycle)

Countries

India

Contacts

Public ContactDr Hitha M K

Government Ayurveda Medical College and Hospital, Mysuru

sudhi130207t@gmail.com9341061821

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026